¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Migration today (Staten Island, New York, N.Y.)"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • new drug application
    ½Å¾àÇã°¡½Åû
  • new tuberculin
    ½ÅÅõº£¸£Äð¸°
  • new world hookworm
    ½Å¼¼°è±¸Ãæ
  • cellular migration
    ¼¼Æ÷À̵¿
  • dorsal thumb island flap
    µîÂʾöÁö¼¶ÇÇÆÇ
  • island
    ¼¶
  • island flap
    ¼¶ÇÇÆÇ, µµ¼­ÇüÇÇÆÇ
  • island population
    °í¸³Àα¸Áý´Ü
  • island scalp flap
    ¼¶¸ð¾ç¸Ó¸®µ¤°³ÇÇÆÇ, µµ»óµÎÇÇÆÇ
  • instep island flap
    ¾ÈÂʹ߹ٴڼ¶ÇÇÆÇ, Á¾Á·Àúµµ¼­ÇüÇÇÆÇ
  • migration
    ÀÌÁÖ, À̵¿
  • migration defect
    ÀÌÁÖ°áÇÔ
  • migration inhibition factor
    À̵¿ÀúÁöÀÎÀÚ
  • migration inhibition test
    À̵¿¾ïÁ¦°Ë»ç, À̵¿ÀúÁö°Ë»ç
  • macrophage migration inhibitory factor
    Å«Æ÷½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ, ´ë½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • migration
    À̵¿, ÀÌÁÖ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • new drug application
    ½Å¾àÇã°¡½Åû
  • new world hookworm
    (¢¡American hookworm) ¾Æ¸Þ¸®Ä«±¸Ãæ
  • dorsal thumb island flap
    µîÂʾöÁö¼¶ÇÇÆÇ
  • instep island flap
    ¾ÈÂʹ߹ٴڼ¶ÇÇÆÇ, Á¾Á·Àúµµ¼­ÇüÇÇÆÇ
  • island flap
    ¼¶ÇÇÆÇ, µµ¼­ÇüÇÇÆÇ
  • island scalp flap
    ¼¶¸ð¾ç¸Ó¸®µ¤°³ÇÇÆÇ, µµ»óµÎÇÇÆÇ
  • neurovascular island flap
    ½Å°æÇ÷°ü¼¶ÇÇÆÇ
  • island
    ¼¶
  • inter-island contraction phenomenon
    ¼¶»çÀ̼öÃàÇö»ó
  • island population
    °í¸³Àα¸Áý´Ü
  • catadromous migration
    °­·ùÀ̵¿
  • cellular migration
    ¼¼Æ÷À̵¿
  • migration defect
    ÀÌÁÖ°áÇÔ
  • macrophage migration inhibitory factor
    Å«Æ÷½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ
  • migration inhibition factor
    Æ÷½Ä¼¼Æ÷À̵¿ÀúÇØÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hearing island
    ûµµ
  • IND : investigational new drug
    ½ÃÇè¿ë½Å¾à.
  • NDA : new drug application
    ½Å¾àÇã°¡½Åû.
  • inhibition test, migration
    À¯ÁÖ¾ïÁ¦½ÃÇè, À¯ÁÖÀúÁö½ÃÇè
  • inhibition(-tory) factor, macrophage migration
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • new bone formation
    ½Å»ý °ñ Çü¼º(ãæßæÍéû¡à÷), ½Å°ñ Çü¼º(ãæÍéû¡à÷).
  • new growth
    ½Å»ý¼º.(º´¸®)½Å»ý¹°(ãæßæÚª).
  • new growth
    ½Å»ý¼º(ãæßæàõ).½Å»ý¹°(ãæßæÚª)
  • new sensation =gnostic s.
    ½Å°¨°¢(ãæÊï ÊÆ), ÀÎÁö¼º °¨°¢(ìãò±àõÊïÊÆ).
  • new thalamus
    ½Å½Ã»ó(ãæãÊßÉ).
  • new tuberculin
    ½ÅÅõº£¸£Äð¸°.
  • new tuberculin
    ½ÅÅõº£¸£Äð¸°.
  • auditory island
    ûµµ
  • blood island
    Ç÷¾×¼¶
  • blood island
    Ç÷¾×¼¶, ÇǼ¶, Ç÷µµ(úìÓö).
  • blood island
    Ç÷¾×¼¶
  • coral island
    »êÈ£¼¶(Ë×Ì´ËÀ).
  • erythroblastic island
    Àû¾Æ±¸¼º ÁýÇÕ
  • hearing island
    ûµµ
  • island fever
    ¼¶¿­(¡­æð).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Migration defect
    ÀÌÁÖ°áÇÔ
    [¿¾ ¿ë¾î] ÀÌÁÖ°áÇÔ
  • Blood island
    Ç÷¾×¼¶
    [¿¾ ¿ë¾î] Ç÷µµ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extraintestinal migration
    Àå¿ÜÀÌÇà (íóèâì¹ú¼)
  • lung migration
    ÆóÀÌÇà
  • somatic migration
    Á¶Á÷ÀÌÇà
  • tracheal migration
    ±â°üÀÌÇà
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • branch migration
    °¡ÁöÀ̵¿(ì¹ÔÑ)
  • bridge migration
    ±³·®À̵¿(ÎéÕÙì¹ÔÑ)
  • eddy migration
    ¿ÍÀ̵¿(è¾ì¹ÔÑ)
  • ionic migration
    À̿ À̵¿(ì¹ÔÑ)
  • migration
    À̵¿(ì¹ÔÑ)
  • migration enhancement factor
    À̵¿Ç×Áø ÀÎÀÚ(ì¹ÔÑùñòäì×í­)
  • migration inhibition factor
    À̵¿ÀúÇØ ÀÎÀÚ(ì¹ÔÑîÁúªì×í­)
  • relative migration distance
    »ó´ë À̵¿°Å¸®(ßÓÓßì¹ÔÑËå×î)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • migration
    ÀÌÁÖ, À̵¿, À¯ÁÖ
  • sclerotic bone island
    °æÈ­¼º°ñ¼¶
  • new bone formation
    ½Å°ñÇü¼º
  • periosteal new bone
    °ñ¸·¼º½Å»ý°ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NYHA New York Heart Association
  Heart Disease¿¡ ´ëÇÑ Functional Classification
 &nbs...
NYC New York City [medium]
NYHA New York Heart Association
NYHAFC New York Heart Association Functional Class
MI first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NY New York
NYC New York City
N.Y.H.A. New York Heart Association
NYS New York State
SUNY State University of New York
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 23339
    JournalTitle: Migration today (Staten Island, New York, N.Y.)
    MedAbbr: Migr Today
    ISSN: 0197-9175
    ESSN:
    IsoAbbr:
    NlmId: 9882228
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • new drug application
    ½Å¾à Çã°¡ ½Åû
  • new or abrupt onset of pain
    »õ·Ó°Å³ª °©ÀÛ½º·¯¿î µ¿ÅëÀÇ ¹ß»ý
  • periosteal new bone
    °ñ¸·¼º ½Å»ý°ñ
  • island of Langerhans
    ¶û°Ô¸£Çѽº ¼¶
  • Landolt's island
    ¶û°Ô¸£Çѽº ¼¶
    ÃéÀå Áß¿¡ ¼¶»óÀ» ÀÌ·ç´Â ³»ºÐºñ ¼± ¼¼Æ÷ÀÇ ÁýÇÕü.
  • Langerhans' island
    ¶û°Ô¸£Çѽº ¼¶
    1. ÃéÀå¿¡ Àִ Ư¼ö ¼¼Æ÷±ºÀ¸·Î¼­, Àν¶¸°À» ºÐºñÇÏ´Â Á¶Á÷. 2. ÃéÀå¿¡¼­ ³»ºÐºñ ±â´ÉÀ» ´ã´çÇÏ´Â ºÎºÐ. ¿ÜºÐºñ¼±µé »çÀÌ¿¡ »êÀçÇÑ´Ù.
  • sclerotic bone island
    °æÈ­¼º °ñ¼¶
  • tone island
    ÀÜû
  • factor macrophage migration inhibition
    ´ë½Ä ¼¼Æ÷ À¯ÁÖ ÀúÁö ÀÎÀÚ
  • lymphocyte migration
    Àӯı¸ À̵¿
  • macrophage migration inhibitory factor
    ´ë½Ä ¼¼Æ÷ À¯ÁÖ ÀúÁö ÀÎÀÚ, °Å½Ä ¼¼Æ÷ À¯ÁÖ ¾ïÁ¦ ÀÎÀÚ
  • migration
    ÀÌÁÖ, À̵¿, À¯ÁÖ, ÀÌÇà, ÀÌÀÔ
    Áõ»ó µîÀÇ ºÎÀ§°¡ ÀÚ¿¬ÀûÀ¸·Î ¸í¹éÇÏ°Ô º¯È­ÇÏ´Â °Í. Ç÷°ü º®À» ÅëÇÑ ¹éÇ÷±¸ÀÇ À̵¿.
  • migration inhibitory factor test
    À¯ÁÖ ÀúÁö ÀÎÀÚ ½ÃÇè
    ƯÀÌ Ç׿ø¿¡ ¹ÝÀÀÇÏ¿© ¸²ÇÁ±¸°¡ MIF¸¦ »ý¼ºÇÏ´Â µ¥ ´ëÇÑ »ýüÀÇ ½ÃÇè¹ýÀ¸·Î ¼¼Æ÷ ¸Å°³ ¸é¿ªÀ» Æò°¡ÇÏ´Â µ¥ »ç¿ëÇÑ´Ù. ÀϺΠ¸é¿ª °áÇÌ Áúº´, Áï DiGeorge ÁõÈıº, Wiskott-Aldrich ÁõÈıº, Hodgkin º´¿¡¼­´Â MIF°¡ »ý¼ºµÇÁö ¾Ê´Â´Ù.
  • migration theory
    À̵¿¼³
  • physiologic migration of the teeth
    »ý¸®Àû Ä¡¾Æ À̵¿
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
New York Heart Association classification A functional classification to assess cardiovascular disability. Class I: patients with cardiac disease without limitation of physical activity. Ordinary activity does not cause symptoms. Class II: patients with cardiac disease with slight limitation of activity; comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea or angina. Class III: patients with cardiac disease producing marked limitation of activity: comfortable at rest. Less than ordinary physical activity causes symptoms. Class IV: patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms may be present even at rest.
(05 Mar 2000)
bam island <molecular biology> Areas of DNA which do not get transcribed, consisting of many repeats of the same sequence of nucleotide bases.
(13 Nov 1997)
blood island An aggregation of splanchnic mesodermal cells on the embryonic yolk sac, with the potentiality of forming vascular endothelium and primitive blood cells.
Synonym: blood islet.
(05 Mar 2000)
bone island <radiology> Small, intramedullary island of compact bone, usually negative on bone scan, shaggy, slightly stellate border, Differential diagnosis: osteoid osteoma, multiple leading to osteopoikilosis
(12 Dec 1998)
branch migration <molecular biology> Movement of the branch point in a branched DNA sequence formed from two parent DNA molecules with practically identical sequences.
(17 Dec 1997)
macrophage migration inhibition test A test which measures the presence of migration-inhibitory factor. Usually peritoneal macrophages are placed in a capillary tube in the presence or absence of supernatants from activated T-cells. If MIF is present, the migration of monocyte/macrophages is reduced.
Synonym: macrophage migration inhibition test, migration inhibition test.
(05 Mar 2000)
macrophage migration-inhibitory factors Proteins released by sensitised lymphocytes and possibly other cells that inhibit the migration of macrophages away from the release site. The structure and chemical properties may vary with the species and type of releasing cell.
(12 Dec 1998)
magnetic island <physics> A magnetic topology near a rational surface where the flux surface is broken up into tubes which are not connected with each other poloidally. Islands may develop in non-ideal magnetohydrodynamic fluids, where electrical resistance becomes important and magnetic field lines are no longer frozen-in to the fluid. Then magnetic tearing and reconnection may allow field lines to link up and form islands with a local magnetic axis in a narrow region near a rational surface. (See also magnetohydrodynamic, frozen-in law). The development of islands may be caused by a small perturbation, whether internal or external, whether deliberate or accidental, and is usually associated with enhanced transport (i.e., reduced confinement). The centres of the islands are magnetic O-points, while the boundaries between islands are marked by X-points.
(09 Oct 1997)
cell migration <cell biology> Implies movement of a population of cells from one place to another as in the movement of neural crest cells during morphogenesis.
(26 Mar 1998)
cell migration inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration-inhibitory factor, immune reactivity against tumour-associated antigens, and immunosuppressive effects of infectious microorganisms.
(12 Dec 1998)
migration 1. Passing from one part to another, said of certain morbid processes or symptoms.
Synonym: diapedesis.
3. Movement of a tooth or teeth out of normal position.
4. Movement of molecules during electrophoresis.
Origin: L. Migro, pp. -atus, to move from place to place
(05 Mar 2000)
migration inhibition test A test which measures the presence of migration-inhibitory factor. Usually peritoneal macrophages are placed in a capillary tube in the presence or absence of supernatants from activated T-cells. If MIF is present, the migration of monocyte/macrophages is reduced.
Synonym: macrophage migration inhibition test, migration inhibition test.
(05 Mar 2000)
migration-inhibitory factor <growth factor> A soluble, nondialysable factor that is produced by sensitised lymphocytes following exposure to a specific antigen. It inhibits macrophage migration and causes adherence.
It was originally defined on the basis of inhibition of emigration of mononuclear cells from capillary (haematocrit) tubes, more recently a 13 kD protein with migration inhibitory activity has been isolated.
Acronym: MIF
Synonym: inhibition factor.
(22 Sep 2002)
migration-inhibitory factor test A test which measures the presence of migration-inhibitory factor. Usually peritoneal macrophages are placed in a capillary tube in the presence or absence of supernatants from activated T-cells. If MIF is present, the migration of monocyte/macrophages is reduced.
Synonym: macrophage migration inhibition test, migration inhibition test.
(05 Mar 2000)
migration of ovum <gynaecology> The transperitoneal passage of an ovum from the ovarian follicle into the uterine tube.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Staten Island
    New York ¸¸ ¾ÈÀÇ ¼¶
  • Greater New York
    ´ë´º¿å(Á¾·¡ÀÇ New York¿¡´Ù°¡ Bronx,Brooklyn,Queens,Richmond¸¦ ÇÕÄ£ °Í)
  • New York
    ´º¿åÁÖ
  • New York City
    ´º¿å½Ã New YorkÁÖ¿¡ ÀÖ´Â ¹Ì±¹ ÃÖ´ëÀÇ µµ½Ã
  • New York School
    ´º¿åÆÄ(1940-50)³â´ë¿¡ New York¿¡ ³ªÅ¸³­ Ãß»ó Ç¥ÇöÁÖÀÇ È­ÆÄ)
  • New York State Barge Canal
    ´º¿åÁê ¿îÇϸÁ
  • New York Stock Exchange
    ´º¿åÁõ±Ç °Å·¡¼­(¼¼°è ÃÖ´ëÀÇ)
  • migration
    ÀÌÁÖ;(ºÐÀÚ³»ÀÇ)¿øÀÚ À̵¿
  • today
    ¿À´Ã,¿À´Ã³¯¿¡
  • today
    ¿À´Ã;ÇöÀç;¿À´Ã³¯
  • York
    ¿äÅ©°¡;1461-85³â °£ÀÇ ¿µ±¹ÀÇ ¿Õ°¡
  • island
    ¼¶
  • Coney Island
    ÄڴϾÆÀÏ·£µå(New York Ç×±¸ÀÇ Long Island¿¡ ÀÖ´Â À¯¿øÁö)
  • Devil's Island
    ¾Ç¸¶ÀÇ ¼¶;ÀÏµÚµð¾Æºí;(ÇÁ¶û½º·É Guiana ¾Õ¹Ù´ÙÀÇ ¼¶,¿ø·¡ À¯Çüµµ)
  • Ellis Island
    ¿¤¸®½º¼¶(´º¿åÇ×ÀÇ ÀÛÀº ¼¶,Àü¿¡ À̹Π°Ë¿ª¼Ò°¡ ÀÖ¾úÀ½)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á